# FDA 483 - Deirdre O. Hooper, M.D. - September 10, 2025

Source: https://www.keypedia.com/records/483/deirdre-o-hooper-md/d0963ac0-7d2d-446a-a714-4ccb3d8a080a

> FDA 483 for Deirdre O. Hooper, M.D. on September 10, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Deirdre O. Hooper, M.D.
- Inspection Date: 2025-09-10
- Product Type: drugs
- Office Name: New Orleans District Office
- Summary: An FDA inspection of Deirdre O. Hooper, M.D., a clinical investigator in New Orleans, LA, revealed issues with data accuracy. Specifically, subject case history records were found to be inaccurate, with discrepancies between electronic data capture (EDC) system entries and original source records for multiple subjects and visits. This indicates a significant concern regarding data integrity in clinical trial documentation.

## Related Officers

- [investigator](https://www.keypedia.com/people/ann-b-borromeo/ca03a531-043c-4195-b100-a8a0fc763159)

Company: https://www.keypedia.com/companies/deirdre-o-hooper-md/66497ec3-68f2-40b7-9b6a-703d333737c7

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea